STAT3 and glioblastoma: It promotes PKM2 tetramer formation in GBM cells, reduces PKM2 nuclear translocation without affecting total PKM2 expression, and thereby inhibits the STAT3 signaling pathway in vitro and in vivo, as a result, it suppresses the proliferation and metastasis of GBM cells and induces apoptosis (93).